Mario Kuperminc

1.3k citations
10 papers · 975 indexed · 1 hit paper · h-index 6
Topics
Cancer Treatment and Pharmacology (3 papers)Cancer, Stress, Anesthesia, and Immune Response (2 papers)Synthesis of Tetrazole Derivatives (1 paper)
Partner nations
United StatesJapan

In The Last Decade

Mario Kuperminc

10 papers receiving 933 citations

Hit Papers

Comparison of Oral Capecitabine Versus Intravenous Fluoro...20012026200920172001250500750

Peers

Mario Kuperminc
Comparison fields: 5 of 73
  • Oncology 825
  • Pulmonary and Respiratory Medicine 264
  • Surgery 198
  • Hepatology 157
  • Pathology and Forensic Medicine 123
Replace John J. Gullo with:
John J. Gullo United States
R. Wong Japan
Yvonne Lassere United States
Christophe Martin France
G. Pérez-Manga Spain
C.G. Alexopoulos Greece
J J Lokich United States
Frédérique Maindrault‐Gœbel France
Rossana Casaretti Italy
Janja Ocvirk Slovenia
Mario Kuperminc relative to John J. Gullo United States John J. Gullo's profile →
Citations per field
00.5×4.9×
John J. Gullo · 1×
Citations per year

Countries citing papers authored by Mario Kuperminc

Since Specialization
Citations

This map shows the geographic impact of Mario Kuperminc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Kuperminc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Kuperminc more than expected).

Fields of papers citing papers by Mario Kuperminc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Kuperminc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Kuperminc. The network helps show where Mario Kuperminc may publish in the future.

Co-authorship network of co-authors of Mario Kuperminc

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Kuperminc. A scholar is included among the top collaborators of Mario Kuperminc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Kuperminc. Mario Kuperminc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1
Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Studybreakdown →
882
2 10
3 29
4 5
5
Phase II study of vindesine in metastatic malignant melanoma.
5
6 10
7 4
8 1
9
Phase I study of tilorone, a non-marrow depressing antitumor agent.
10
10
Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer.
19

About Mario Kuperminc

Mario Kuperminc is a scholar working on Cancer Research, Psychiatry and Mental health and Oncology, having authored 10 papers that have together received 975 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Synthesis of Tetrazole Derivatives (1 paper). The work is most often cited by research in Oncology (825 citations), Hepatology (157 citations) and Dermatology (79 citations). Mario Kuperminc has collaborated with scholars based in United States and Japan. Frequent co-authors include A. Wong, Jean A. Maroun, R. Wong, Rafat Ansari, Evelyn B. Harrison, B Osterwalder, Walter Kocha, David Walde, John V. Cox and Paulo M. Hoff. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026